The T11 (CD2) sheep-erythrocyte-binding protein is a T-cell surface molecule involved in activation of T lymphocytes and thymocytes, including those lacking the T3-Ti antigen-receptor complex. The primary structure of Til was deduced from protein microsequencing and cDNA cloning. The mature human protein appears to be divided into three domains: a hydrophilic 185 amino acid external domain bearing only limited homology to the T-cell surface protein T4 and the immunoglobulin K light chain variable region, a 25 amino acid hydrophobic transmembrane segment, and a 126 amino acid cytoplasmic domain rich in prolines and basic residues. Transfection of cDNAs encoding either the 1.7-or the 1.3-kilobase Til mRNA into COS-1 cells resulted in expression of surface Til epitopes as well as sheep-erythrocyte-binding capacity. The predicted structure is consistent with the possibility that Til functions in signal transduction.Human thymus-derived (T) lymphocytes were originally distinguished from B lymphocytes and other hematopoietic cells by their ability to form spontaneous aggregates (E rosettes) with sheep erythrocytes (SRBCs) (1-3). Congenital hypoplasia of the thymus results in loss or significant diminution of peripheral blood E-rosette-forming cells, thus attesting to the importance of the thymus in the maturation of lymphocytes bearing surface receptors for SRBCs.The structure mediating the SRBC binding property is a 50-kDa single-chain cell surface protein (4)(5)(6)(7)(8). Three distinct surface epitopes termed T111, T112, and T113 can be defined. Whereas the T111 and T112 epitopes are expressed on both resting and activated T cells, T113 is spatially distinct and preferentially expressed after T-lineage activation. The SRBC binding site on T11 appears to be identical or closely associated with the T111 epitope, because antibodies to T111 but not T112 or T113 block the ability of SRBCs to form rosettes with T lymphocytes (8). Perhaps more important, antibodies to the T111 epitope also broadly inhibit T-cell responses. In contrast, a combination of anti-T112 plus anti-T113 induces interleukin 1 (IL-1)-independent polyclonal T-cell activation. Thus, interaction of monoclonal antibodies with the T11 structure produces either profound agonistic or antagonistic effects on T-cell activation.Stimulation of T cells through T11, like that occurring through the T3-Ti antigen/MHC receptor complex (which recognizes antigen in the context of major histocompatibility complex-encoded proteins), is mediated via an interleukin 2 (IL-2)-dependent pathway involving activation of endogenous IL-2 and IL-2-receptor genes (8). Nevertheless, these surface structures are not physically linked to one another, since (i) immunoprecipitation and comodulation studies fail to demonstrate any association between T11 and individual T3-Ti subunits (9) and (ii) the T11 pathway functions in early thymocytes and natural killer cells, both of which lack the surface T3-Ti complex (10, 11).Given that T11 is more phylogenetically conserved than any ...